Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/29/25 16:52 | 7/28/25 | CALC | Health | Drug | Pharmaceutical Preparations | Stauderman Kenneth A. | CA | O | Chief Sc | 2 | P | 6 | 2.91 | 0 | 2 | 18 | 13 | M | ||||||||||||||
7/23/25 11:55 | 7/22/25 | CALC | Health | Drug | Pharmaceutical Preparations | Roberts Eric W | CA | DOT | CHIEF BU | 8 | P.m | 74 | 2.04 | 0 | 36 | 4 | 1,014 | I | ||||||||||||||
7/21/25 14:02 | 7/21/25 | CALC | Health | Drug | Pharmaceutical Preparations | Leheny A. Rachel | CA | DOT | CEO | 2 | P | 10 | 2.74 | 0 | 4 | 0 | 875 | I | ||||||||||||||
7/18/25 14:42 | 7/18/25 | CALC | Health | Drug | Pharmaceutical Preparations | Wilson Robert N | CA | D | 1 | P | 13 | 2.87 | 0 | 5 | 1 | 422 | D | |||||||||||||||
6/26/25 18:30 | 6/26/25 | CALC | Health | Drug | Pharmaceutical Preparations | Bardin Stephen | CA | O | CFO | 2 | P.d | 5 | 1.57 | 0 | 3 | 8 | 43 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |